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Introduction 
Ischaemic heart disease is one of the leading causes of 
death in Pakistan.1 
Diagnosis of ischaemic heart disease is essential for both 
management and risk stratification. Myocardial perfusion 
stress imaging (MPI) helps diagnose suspected ischaemic 
heart disease and risk stratification of patients with 
known ischaemic heart disease. 
The risk of death and myocardial infarction (MI) is 
approximately 1% in both United States and Pakistan in 
patients with normal MPI.2,3 Several studies have shown 
that in single-photon emission computed tomography 
(SPECT) MPI with exercise stress testing, ECG changes 
alone have no significant effect on diagnostis and 
prognosis.4-8 Years ago, studies suggested that ECG 
changes during vasodilator infusion with normal MPI 
predict increased risk of future cardiac events.9,10 
However, subsequent studies demonstrated 
contradictory results.11,12 Previous studies proposed that 
electrocardiogram (ECG) changes with normal MPI 
revealed poor prognosis in the MPI with a dobutamine 
stress test.13,14 
There is a paucity of data combining the results of normal 
MPI with abnormal ECG in both exercise and 
pharmacologic stress tests. Also, there is a lack of research 
data from Pakistan. The current study was planned to 
determine the prognostic value of ischaemic ECG 
changes with normal MPI in both exercise and 
pharmacological stress tests. 
Patients and Methods 
The retrospective study was conducted at the Aga Khan 
University Hospital (AKUH), Karachi, and comprised 
patient data from January 2013 to December 2014. Data 
was retrieved after getting approval from the institutional 
ethics review committee. Data collected related to 
patients who underwent either pharmacological or 
exercise stress MPI at AKUH during the specified period. 
Data of only those patients were included who developed 
Ischaemic ECG changes during the stress, but had normal 
MPI. Ischaemic ECG changes were defined as horizontal or 
down-sloping ST-segment depression of >1mm at 60ms 
after the J point, or up-sloping ST depression of >1.5mm 
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Abstract 
Objectives: To evaluate cardiovascular outcomes in patients with normal nuclear myocardial perfusion imaging, 
but ischaemic electrocardiogram changes during pharmacological or exercise stress tests.  
Methods: The retrospective study was conducted at the Aga Khan University Hospital, Karachi, and comprised data 
of patients who underwent either pharmacological or exercise stress myocardial perfusion scan and had a normal 
scan with ischaemic electrocardiogram changes between January 2013 and December 2014. All cardiac events, 
including angina, myocardial infarction, heart failure, coronary revascularisation and cardiac death, as well as non-
cardiac deaths were noted.  Data was analysed using STATA 14.2. 
Results: Of the 2770 patients whose data was initially checked, 296(10.6%) developed ischaemic electrocardiogram 
changes during the stress test but had normal myocardial perfusion scan. Of them, 181(61%) patients were male, 
and the overall mean age was 62±15 years. Follow-up data was available for 280(94.5%) of these patients, with a 
mean follow-up of 48±7 months. Of these patients, 8(2.8%) died, and 1(0.3%) of them died due to inferior wall 
myocardial infarction. Myocardial infarction was found in 2(0.7%) patients, and 1(0.3%) patient was hospitalised 
with heart failure. Also, 12(4.3%) patients underwent revascularization for stable angina, 9(3.2%) underwent 
percutaneous transluminal coronary angioplasty, and 3(1.07%) needed coronary artery bypass grafting. 
Conclusion: Ischaemic electrocardiographic changes during stress testing in patients with normal myocardial 
perfusion scan were not associated with adverse outcomes, and the risk of cardiovascular events was relatively low 
for an intermediate follow-up period. 
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at 80ms after the J point.15 Patients with baseline ECG 
changes and abnormal scans were excluded. 
The sample size was calculated to achieve 80% power at 
5% level of significance with a non-response rate of 10%. 
As a general protocol, all patients had been kept nil-per-
oral (NPO) for 6 hours before stress MPI and had been 
asked to withhold anti-anginal medications, like nitrates, 
beta-blockers and calcium channel blockers, as well as 
caffeine-containing food and drugs 24 hours before 
testing. The ECG and vital signs were monitored before 
and during the test.  
All patients had then undergone a symptom-limited 
exercise tolerance test (ETT) using the Bruce protocol.16 At 
peak exercise, with at least 85% age-predicted heart rate 
or upon the development of symptoms, Tc-99m 
tetrofosmin was given, and the patient was made to 
continue exercising for one minute post-injection. 
Dipyridamole was administered at a standard infusion 
rate of 0.56mg/kg intravenously (IV) over 4 minutes. The 
radiotracer was injected 4 minutes after the completion of 
dipyridamole infusion.  
Dobutamine was infused at standard protocol with 
incrementally starting at a dose of 5-10mcg/kg/min, 
which was increased at 3-minute intervals to 20, 30 and 
40mcg/kg/min. Radiotracer was injected at peak heart 
rate with dobutamine infusion continuing for 1 minute 
following tracer injection. 
Image acquisition and processing were performed within 
the guidelines of the American Society of Nuclear 
Cardiology.17 All patients underwent a 1-day study 
protocol, one image taken at rest, and one image taken 
after 15-30 minutes of exercise and pharmacological 
stress. 
Follow up was performed by reviewing hospital medical 
records and patients whose records were not available 
were also contacted via telephone to get information 
about their medical status and occurrence of any cardiac 
event till date.  
Events were defined as major adverse cardiac events 
(MACE), including cardiovascular death, MI, heart failure 
(HF) and revascularisation.  
Data was analysed using STATA 14.2. For descriptive 
analysis, frequencies and percentages were computed to 
assess the distribution of qualitative variables. Measures 
of central tendency were computed for quantitative 
variables. 
For inferential analysis, two groups of patients, exercise 
and pharmacological, were compared for all their 
characteristics using chi-square test for qualitative 
variables with >5 cell frequency, Fisher's exact for 
qualitative variables with <5 cell frequency, and z-test for 
proportions was used to compute the difference. P<0.05 
was considered significant. 
Results 
Of the 2770 patients whose data was initially checked, 
296(10.6%) were enrolled. Of them, 181(61%) patients 
were male, and the overall mean age was 62±15 years. 
Follow-up data was available for 280(94.5%) of these 
patients, with a mean follow-up of 48±7 months. Of these, 
221(79%) had exercise stress, 36(12.8%) had vasodilator 
stress and 23(8.2%) dobutamine stress. The most 
common indication of scan was typical chest pain 
62(22%). The mean left ventricular ejection fraction (LVEF) 
was 63±4% (Table-1). 
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Table-1: Baseline characteristics. 
 
Characteristics                                             Exercise          Pharmacological          P value 
(n=279)                                                           (n=221)                    (n=58)                             
 
Mean age (years)                                              61±15                        64±9                          0.11 
Males n=181                                                  170(77%)                   11(19%)                   P<0.001 
HTN n=204                                                      153(69%)                  51(87%)                    P<0.01 
Diabetes n=126                                              93 (42%)                   33(57%)                       0.04 
Dyslipidaemia                                                  98 (44%)                   27(47%)                       0.76 
Smoker n=20                                                   19 (9%)                       1(2%)                          0.07 
LVEF (mean%±SD)                                         63%±4                      61%±4                      <0.01 
Indication 
Typical chest pain                                           46(21%)                    16(28%)                       0.27 
Atypical chest pain                                         97(44%)                    16(28%)                       0.02 
Shortness of breath                                        43(20%)                    11(20%)                       0.93 
Pre op risk stratification                                  8(4%)                      10(17%)                    <0.001 
Palpitation                                                           4(2%)                         3(5%)                          0.14 
LV dysfunction                                                    3(1%)                         2(3%)                          0.28 
Positive ETT                                                        20(9%)                             0                               0.01 
ECG  
Time taken to resolve ST depression      6±4 mins                  6±3 mins                      0.78 
 
DSD: Standard deviation, HTN: Hypertension, LVEF: Left ventricular ejection fraction, LV: Left 
ventricle, ETT: Excercie tolerance test, ECG: Electrocardiogram.
Table-2: Follow-up events. 
 
Events                                                Exercise (n=221)                  Pharmacologic (n=58) 
 
MI                                                                    1(0.45%)                                              1(2%) 
Heart failure                                                1(0.45%)                                                   0 
Revascularization 
Angioplasty                                                     7(3%)                                                 2(3%) 
CABG                                                                  2 (1)                                                  1(2%) 
All cause mortality                                      6 (3%)                                                2(3%) 
Death due to cardiac cause                            0                                                      1 (2%) 
 
MI: Myocardial infarction, CABG: Coronary artery bypass graft.
On follow-up, 1(0.3%) patient had Non-ST elevation 
myocardial infarction (NSTEMI), 1(0.3%) had inferior wall 
MI and 1(0.3%) was hospitalised due to HF (Table-2). One 
(0.3%) patient who had heart failure was later found to 
have non-ischaemic valvular heart disease on 
echocardiography. Further, 11(3.9%) patients underwent 
coronary revascularisation, 8(2.8%) had coronary 
angioplasty and 3(1.07%) had coronary artery bypass 
grafting (CABG). The incidence of all-cause mortality was 
8(2.8%); 2(25%) each related to sepsis and cancer, and 
1(12.5%) each related to inferior ST-elevation MI (STEMI), 
ischaemic stroke, acute renal failure and road traffic 
accident (RTA) not related to any cardiac cause. 
Discussion 
To the best of our knowledge, this is the first study from 
Pakistan exploring the prognostic value of ischaemic ECG 
changes during both pharmacological and exercise stress 
test with normal MPI. The study demonstrated that the 
combination of ischaemic ECG changes during stress and 
normal MPI was not common. However, it was more 
common than reported in literature.9-11 In our study, most 
patients with ECG changes during stress and normal MPI 
were men. This is also different from previous studies in 
which ischaemic changes were more common among 
women.9,10,12 This difference could be because of the fact 
that fewer women are referred for stress MPI in Pakistan 
due to cultural factors. By looking at the number of 
patients who had hypertension (73%) and diabetes 
mellitus (45%) in this study, it can be said that this was 
mainly an intermediate-risk population.  
During the follow-up, the number of patients who 
developed MI, HF or cardiovascular death was low, and, 
similarly, the incidence of cardiovascular mortality was 
very low. It indicates that the ischaemic ECG changes had 
low prognostic value in the presence of standard MPI, 
with either exercise or pharmacological stress test. 
Previous studies showed conflicting results in these 
patients.8-11 During a pharmacological stress test, the ST-
segment depression is thought to represent myocardial 
ischaemic secondary to coronary steal. In the setting of 
normal perfusion images, this can only occur if there is a 
perfectly balanced decrease in perfusion in the coronary 
arteries. This mechanism is called balanced ischaemia. 
Balanced ischaemia might have been the reason behind 
normal images despite ischaemic ECG changes during 
stress. However, by showing a low incidence of cardiac 
events, the current study did not favour the concept of 
balanced ischaemia in these patients on intermediate 
follow-up. 
In terms of limitations, the present study was a single-
centre retrospective cohort, and its findings cannot be 
generalised.  Multi-centre studies with larger sample size 
are recommended. 
Conclusion 
Ischaemic ECG changes during pharmacological or 
exercise stress with normal MPS did not add prognostic 
data to perfusion images.  
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